[1] HUMPHREY L L,DEFFEBACH M,PAPPAS M,et al.Screening for lung cancer with low-dose computed tomography:a systematic review to update the US Preventive services task force recommendation[J].Ann Intern Med,2013,159(6):411-420.
[2] YOSHIZAWA A,MOTOI N,RIELY G J,et al.Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma:prognostic subgroups and implications for further revision of staging based on analysis of 514 stage Ⅰ cases[J].Modern Pathol,2011,24(5):653-664.
[3] TRAVIS W D,BRAMBILLA E,NOGUCHI M,et al.International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma[J].J Thorac Oncol,2011,6(2):244-285.
[4] WENG S,TSUCHIYA E,SATOH Y,et al.Multiple atypical adenomatous hyperplasia of type-Ⅱ pneumonocytes and bronchiolo-alveolar carcinoma[J].Histopathology,1990,16(1):101-103.
[5] YOKOSE T,DOI M,TANNO K,et al.Atypical adenomatous hyperplasia of the lung in autopsy cases[J].Lung Cancer,2001,33(2-3):155-161.
[6] PARK C M,GOO J M,LEE H J,et al.CT findings of atypical adenomatous hyperplasia in the lung[J].Korean J Radiol,2006,7(2):80-86.
[7] PARK B M,CHO M J,LEE H S,et al.A case of atypical adenomatous hyperplasia of larger than 2 cm[J].Tuberc Respir Dis,2013,74(6):280-285.
[8] LEE S M,GOO J M,PARK C M,et al.A new classification of adenocarcinoma:what the radiologists need to know[J].Diagn Interv Radiol,2012,18(6):519-526.
[9] BORCZUK A C.Assessment of invasion in lung adenocarcinoma classification,including adenocarcinoma in situ and minimally invasive adenocarcinoma[J].Modern Pathol,2012,25(Suppl 1):S1-10.
[10] JONES K D.Whence lepidic?:the history of a Canadian neologism[J].Arch Pathol Lab Med,2013,137(12):1822-1824.
[11] WATANABE S,WATANABE T,ARAI K,et al.Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography[J].Ann Thorac Surg,2002,73(4):1071-1075.
[12] SAKURAI H,DOBASHI Y,MIZUTANI E,et al.Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter:a prognostic assessment[J].Ann Thorac Surg,2004,78(5):1728-1733.
[13] YIM J,ZHU L C,CHIRIBOGA L,et al.Histologic features are important prognostic indicators in early stages lung adenocarcinomas[J].Modern Pathol,2007,20(2):233-241.
[14] MAESHIMA A M,TOCHIGI N,YOSHIDA A,et al.Histological scoring for small lung adenocarcinomas 2 cm or less in diameter:a reliable prognostic indicator[J].J Thorac Oncol,2010,5(3):333-339.
[15] KADOTA K,YEH Y C,D'ANGELO S P,et al.Associations between mutations and histologic patterns of mucin in lung adenocarcinoma invasive mucinous pattern and extracellular mucin are associated with KRAS mutation[J].Am J Surg Pathol,2014,38(8):1118-1127.
[16] SUGANO M,NAGASAKA T,SASAKI E,et al.HNF4 alpha as a marker for invasive mucinous adenocarcinoma of the lung[J].Am J Surg Pathol,2013,37(2):211-218.
[17] SAKAO Y,MIYAMOTO H,SAKURABA M,et al.Prognostic significance of a histologic subtype in small adenocarcinoma of the lung:The impact of nonbronchioloalveolar carcinoma components[J].Ann Thorac Surg,2007,83(1):209-215.
[18] LIM H J,AHN S,LEE K S,et al.Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan histopathologic comparisons and prognostic implications[J].Chest,2013,144(4):1291-1299.
[19] 吴芳,蔡祖龙,田树平,等.1cm以下磨玻璃密度肺腺癌的CT征象与病理亚型及免疫组织化学的相关性[J].中国医学科学院学报,2015,37(2):163-170.
[20] ROSELL R,MORAN T,QUERALT C,et al.Screening for epidermal growth factor receptor mutations in lung cancer[J].NEJM,2009,361(10):958-967.
[21] LIU Y,XU M L,ZHONG H H,et al.EGFR mutations are more frequent in well-differentiated than in poor-differentiated lung adenocarcinomas[J].POR,2008,14(4):373-379.
[22] HONG S J,KIM T J,CHOI Y W,et al.Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations:Imaging features and histological subtypes[J].Eur Radiol,2016,26(10):3660-3668.
[23] RIZZO S,PETRELLA F,BUSCARINO V,et al.CT radiogenomic characterization of EGFR,K-RAS,and ALK mutations in non-small cell lung cancer[J].Eur Radiol,2016,26(1):32-42.
[24] KOBAYASHI Y,MITSUDOMI T,SAKAO Y,et al.Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules:the differences between nodules with and without growth[J].Ann Oncol,2015,26(1):156-161.
[25] DACIC S.Molecular genetic testing for lung adenocarcinomas:a practical approach to clinically relevant mutations and translocations[J].J Clin Pathol,2013,66(10):870-874.
[26] YAMAMOTO S,KORN R L,OKLU R,et al.ALK molecular phenotype in non-small cell lung cancer:CT radiogenomic characterization[J].Radiology,2014,272(2):568-576. |
